Emcure Pharmaceuticals Limited Share Price & Analysis
₹1,756.8▲ +0.66%Updated 5 Jun 2026, 05:02 pm IST
LTP
₹1,756.8
+0.66%
Open
₹—
High
₹1,796.7
Low
₹1,746
Close
₹1,756.8
52W High
₹1,830
52W Low
₹1,229
Volume
117K
Lot Size
1
Sector
Healthcare
Market Cap
₹32K Cr
Face Value
₹10
Large CapNIFTY 500
Price Chart
Fundamentals
P/E
34.2
Sector P/E
48.9
P/B
6.73
EPS
₹45.89
ROE
20.1%
ROCE
24%
D/E Ratio
0.31
Div Yield
0.18%
Book Value
₹261
+
Strengths
- ✓Excellent return on equity (ROE 20.1%)
- ✓Efficient capital deployment (ROCE 24%)
- ✓Attractively valued vs sector (P/E 34.2x vs industry 48.9x)
- ✓Low debt relative to equity (D/E 0.3x)
Peer Comparison
| Company | CMP | Mkt Cap | P/E | P/B | ROE % | ROCE % | D/E |
|---|---|---|---|---|---|---|---|
| SUNPHARMA Sun Pharmaceutical Industries Limited | ₹1,783 | ₹4.3L Cr | 34.4 | 5.12 | 16 | 20.5 | 0.07 |
| DIVISLAB Divi's Laboratories Limited | ₹6,616 | ₹1.7L Cr | 66.1 | 10.48 | 16.5 | 22 | 0.01 |
| TORNTPHARM Torrent Pharmaceuticals Limited | ₹4,416 | ₹1.5L Cr | 66.4 | 17.81 | 27.6 | 15.4 | 0.33 |
| APOLLOHOSP Apollo Hospitals Enterprise Limited | ₹8,315 | ₹1.2L Cr | 59.5 | 12.62 | 22.1 | 17.9 | 0.88 |
| CIPLA Cipla Limited | ₹1,402 | ₹1.1L Cr | 27.3 | 3.29 | 12.4 | 16.6 | 0.01 |
| ZYDUSLIFE Zydus Lifesciences Limited | ₹1,091 | ₹1.1L Cr | 20 | 4.05 | 21.2 | 21.2 | 0.38 |
| DRREDDY Dr. Reddy's Laboratories Limited | ₹1,283 | ₹1.1L Cr | 25.4 | 2.83 | 11.8 | 13.6 | 0.16 |
Showing 7 peers in the same sector · Sorted by market cap
Shareholding Pattern
EMCURE · as of Mar 2026
Promoters77.87%
FII3.35%▼0.24
DII6.10%
Public12.69%▲0.26
| Category | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoters | 77.94% | 77.92% | 77.92% | 77.88% | 77.87% | 77.87% |
| FII | 3.05% | 3.06% | 2.86% | 3.29% | 3.59% | 3.35% |
| DII | 3.87% | 3.44% | 2.84% | 4.36% | 6.10% | 6.10% |
| Public | 15.15% | 15.58% | 16.39% | 14.46% | 12.43% | 12.69% |
Corporate Events
To consider and approve the financial results for the period ended March 31, 2026 and dividend
Dividend4 May 2026
Dividend - Rs 3 Per Share
Dividend13 Aug 2025
Financials
Quarterly Results
| Metric | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹2.4K Cr ▲4.1% | ₹2.3K Cr ▲8.0% | ₹2.1K Cr ▼0.7% | ₹2.1K Cr ▲7.8% | ₹2.0K Cr ▼1.9% | ₹2.0K Cr ▲10.3% | ₹1.8K Cr ▲2.5% | ₹1.8K Cr |
| Op. Profit | ₹493 Cr ▲3.8% | ₹475 Cr ▲13.9% | ₹417 Cr ▲3.7% | ₹402 Cr ▲13.2% | ₹355 Cr ▼6.8% | ₹381 Cr ▲13.4% | ₹336 Cr ▲8.0% | ₹311 Cr |
| OPM | 21.0% ▲0.0% | 21.0% ▲5.0% | 20.0% ▲5.3% | 19.0% ▲5.6% | 18.0% ▼5.3% | 19.0% ▲0.0% | 19.0% ▲5.6% | 18.0% |
| Net Profit | ₹231 Cr ▼8.0% | ₹251 Cr ▲16.7% | ₹215 Cr ▲9.1% | ₹197 Cr ▲26.3% | ₹156 Cr ▼22.8% | ₹202 Cr ▲32.0% | ₹153 Cr ▲26.4% | ₹121 Cr |
| EPS (₹) | 12.16 ▼5.3% | 12.84 ▲17.6% | 10.92 ▲9.5% | 9.97 ▲22.9% | 8.11 ▼21.2% | 10.29 ▲29.4% | 7.95 ▲25.0% | 6.36 |
Values in ₹ Cr · Source: Screener.in
Annual Profit & Loss
| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹9.2K Cr ▲16.6% | ₹7.9K Cr ▲18.6% | ₹6.7K Cr ▲11.2% | ₹6.0K Cr ▲2.2% | ₹5.9K Cr ▲16.3% | ₹5.0K Cr ▼0.3% | ₹5.0K Cr ▲7.0% | ₹4.7K Cr |
| Expenses | ₹7.3K Cr ▲14.2% | ₹6.4K Cr ▲18.4% | ₹5.4K Cr ▲13.0% | ₹4.8K Cr ▲6.2% | ₹4.5K Cr ▲18.5% | ₹3.8K Cr ▼12.1% | ₹4.3K Cr ▲9.4% | ₹4.0K Cr |
| Op. Profit | ₹1.9K Cr ▲27.0% | ₹1.5K Cr ▲19.4% | ₹1.2K Cr ▲4.1% | ₹1.2K Cr ▼11.1% | ₹1.3K Cr ▲9.4% | ₹1.2K Cr ▲71.8% | ₹708 Cr ▼5.5% | ₹749 Cr |
| OPM | 20.0% ▲5.3% | 19.0% ▲5.6% | 18.0% ▼10.0% | 20.0% ▼13.0% | 23.0% ▼4.2% | 24.0% ▲71.4% | 14.0% ▼12.5% | 16.0% |
| Other Income | ₹-19 Cr ▼130.6% | ₹62 Cr ▲31.9% | ₹47 Cr ▲20.5% | ₹39 Cr ▼38.1% | ₹63 Cr ▲139.6% | ₹-159 Cr ▼536.0% | ₹-25 Cr ▼134.7% | ₹72 Cr |
| Interest | ₹144 Cr ▼18.2% | ₹176 Cr ▼25.7% | ₹237 Cr ▲10.7% | ₹214 Cr ▲21.6% | ₹176 Cr ▲13.5% | ₹155 Cr ▼39.7% | ₹257 Cr ▲15.2% | ₹223 Cr |
| Depreciation | ₹415 Cr ▲8.1% | ₹384 Cr ▲23.1% | ₹312 Cr ▲20.0% | ₹260 Cr ▲6.1% | ₹245 Cr ▼2.0% | ₹250 Cr ▼22.1% | ₹321 Cr ▲20.2% | ₹267 Cr |
| PBT | ₹1.3K Cr ▲32.5% | ₹971 Cr ▲33.6% | ₹727 Cr ▼2.7% | ₹747 Cr ▼23.2% | ₹973 Cr ▲49.2% | ₹652 Cr ▲521.0% | ₹105 Cr ▼68.3% | ₹331 Cr |
| Tax % | 27.0% ▲0.0% | 27.0% ▲0.0% | 27.0% ▲8.0% | 25.0% ▼10.7% | 28.0% ▼22.2% | 36.0% ▲800.0% | 4.0% ▼89.2% | 37.0% |
| Net Profit | ₹941 Cr ▲33.1% | ₹707 Cr ▲33.9% | ₹528 Cr ▼6.0% | ₹562 Cr ▼20.1% | ₹703 Cr ▲67.8% | ₹419 Cr ▲314.9% | ₹101 Cr ▼51.7% | ₹209 Cr |
| EPS (₹) | 48.76 ▲35.6% | 35.96 ▲30.8% | 27.5 ▼6.5% | 29.42 ▼19.7% | 36.62 ▲58.2% | 23.15 ▲401.1% | 4.62 ▼57.2% | 10.79 |
| Div Payout | 0.0% ▼100.0% | 8.0% ▲14.3% | 7.0% ▲0.0% | 7.0% ▼12.5% | 8.0% ▲100.0% | 4.0% ▼92.6% | 54.0% ▲68.8% | 32.0% |
Values in ₹ Cr · Source: Screener.in
Balance Sheet
| Item | Mar 2026 | Sep 2025 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
|---|---|---|---|---|---|---|---|---|---|
| Liabilities | |||||||||
| Equity Capital | ₹190 Cr ▲0.0% | ₹190 Cr ▲0.5% | ₹189 Cr ▲4.4% | ₹181 Cr ▲0.0% | ₹181 Cr ▲0.0% | ₹181 Cr ▲0.0% | ₹181 Cr ▲0.0% | ₹181 Cr ▲0.0% | ₹181 Cr |
| Reserves | ₹4.8K Cr ▲4.5% | ₹4.6K Cr ▲7.0% | ₹4.3K Cr ▲53.6% | ₹2.8K Cr ▲19.4% | ₹2.3K Cr ▲28.4% | ₹1.8K Cr ▼13.6% | ₹2.1K Cr ▲20.9% | ₹1.7K Cr ▲4.7% | ₹1.7K Cr |
| Borrowings | ₹1.6K Cr ▼6.1% | ₹1.7K Cr ▲62.2% | ₹1.0K Cr ▼56.2% | ₹2.3K Cr ▲0.0% | ₹2.3K Cr ▲5.3% | ₹2.2K Cr ▼4.0% | ₹2.3K Cr ▼0.7% | ₹2.3K Cr ▲9.4% | ₹2.1K Cr |
| Other Liabilities | ₹3.1K Cr ▲3.8% | ₹3.0K Cr ▲12.7% | ₹2.7K Cr ▲9.5% | ₹2.4K Cr ▲34.7% | ₹1.8K Cr ▼1.0% | ₹1.8K Cr ▼16.8% | ₹2.2K Cr ▲26.9% | ₹1.7K Cr ▲6.7% | ₹1.6K Cr |
| Total Liabilities | ₹9.6K Cr ▲2.3% | ₹9.4K Cr ▲15.6% | ₹8.1K Cr ▲5.4% | ₹7.7K Cr ▲16.2% | ₹6.6K Cr ▲10.2% | ₹6.0K Cr ▼11.0% | ₹6.8K Cr ▲13.6% | ₹6.0K Cr ▲6.9% | ₹5.6K Cr |
| Assets | |||||||||
| Fixed Assets | ₹3.4K Cr ▲3.4% | ₹3.3K Cr ▲3.5% | ₹3.2K Cr ▲2.3% | ₹3.1K Cr ▲45.6% | ₹2.1K Cr ▲5.0% | ₹2.0K Cr ▼6.6% | ₹2.2K Cr ▼8.1% | ₹2.4K Cr ▲6.0% | ₹2.2K Cr |
| CWIP | ₹172 Cr ▲19.4% | ₹144 Cr ▼18.6% | ₹177 Cr ▲11.3% | ₹159 Cr ▼61.3% | ₹411 Cr ▲28.4% | ₹320 Cr ▲6.0% | ₹302 Cr ▼37.7% | ₹485 Cr ▼16.5% | ₹581 Cr |
| Investments | ₹20 Cr ▼52.4% | ₹42 Cr ▼55.8% | ₹95 Cr ▼70.1% | ₹318 Cr ▲1172.0% | ₹25 Cr ▲0.0% | ₹25 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Other Assets | ₹6.0K Cr ▲1.7% | ₹5.9K Cr ▲26.8% | ₹4.7K Cr ▲13.2% | ₹4.1K Cr ▲1.4% | ₹4.0K Cr ▲11.5% | ₹3.6K Cr ▼15.1% | ₹4.3K Cr ▲38.3% | ₹3.1K Cr ▲12.5% | ₹2.7K Cr |
| Total Assets | ₹9.6K Cr ▲2.3% | ₹9.4K Cr ▲15.6% | ₹8.1K Cr ▲5.4% | ₹7.7K Cr ▲16.2% | ₹6.6K Cr ▲10.2% | ₹6.0K Cr ▼11.0% | ₹6.8K Cr ▲13.6% | ₹6.0K Cr ▲6.9% | ₹5.6K Cr |
Values in ₹ Cr · Source: Screener.in
Cash Flow Statement
| Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
|---|---|---|---|---|---|---|---|---|
| Operating CF | ₹944 Cr ▲10.8% | ₹852 Cr ▼22.3% | ₹1.1K Cr ▲46.9% | ₹747 Cr ▼2.7% | ₹768 Cr ▲9.1% | ₹704 Cr ▲40.8% | ₹500 Cr ▲12.6% | ₹444 Cr |
| Investing CF | ₹-1.2K Cr ▼1142.7% | ₹-96 Cr ▲86.6% | ₹-715 Cr ▼52.8% | ₹-468 Cr ▲18.5% | ₹-574 Cr ▼124.2% | ₹-256 Cr ▼52.4% | ₹-168 Cr ▲58.9% | ₹-409 Cr |
| Financing CF | ₹343 Cr ▲142.1% | ₹-814 Cr ▼396.3% | ₹-164 Cr ▼13.1% | ₹-145 Cr ▲4.6% | ₹-152 Cr ▲19.6% | ₹-189 Cr ▲37.2% | ₹-301 Cr ▲59.0% | ₹-735 Cr |
| Net Cash Flow | ₹94 Cr ▲262.1% | ₹-58 Cr ▼126.5% | ₹219 Cr ▲63.4% | ₹134 Cr ▲219.0% | ₹42 Cr ▼83.8% | ₹259 Cr ▲709.4% | ₹32 Cr ▲104.6% | ₹-700 Cr |
| Free Cash Flow | ₹400 Cr ▼15.8% | ₹475 Cr ▼40.7% | ₹801 Cr ▲132.2% | ₹345 Cr ▼1.1% | ₹349 Cr ▼38.9% | ₹571 Cr ▲57.7% | ₹362 Cr ▲828.2% | ₹39 Cr |
Values in ₹ Cr · Source: Screener.in
Key Ratios History
| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
|---|---|---|---|---|---|---|---|---|
| Debtor Days | 102d ▲9.7% | 93d ▼8.8% | 102d ▲1.0% | 101d ▲23.2% | 82d ▼23.4% | 107d ▲28.9% | 83d ▲10.7% | 75d |
| Inventory Days | 237d ▲5.8% | 224d ▼0.4% | 225d ▲0.9% | 223d ▼5.9% | 237d ▼19.1% | 293d ▲38.9% | 211d ▼9.8% | 234d |
| Days Payable | 175d ▲1.7% | 172d ▼10.9% | 193d ▲10.3% | 175d ▼4.9% | 184d ▼2.1% | 188d ▲41.4% | 133d ▼6.3% | 142d |
| Cash Conv. Cycle | 163d ▲12.4% | 145d ▲8.2% | 134d ▼9.5% | 148d ▲9.6% | 135d ▼36.3% | 212d ▲31.7% | 161d ▼3.6% | 167d |
| Working Capital Days | 62d ▼18.4% | 76d ▲171.4% | 28d ▲27.3% | 22d ▲144.4% | 9d ▲156.3% | -16d ▲42.9% | -28d ▼86.7% | -15d |
| ROCE | 24.0% ▲14.3% | 21.0% ▲10.5% | 19.0% ▼9.5% | 21.0% ▼19.2% | 26.0% ▲18.2% | 22.0% ▲100.0% | 11.0% | — |
Source: Screener.in · Lower days = better efficiency
About Emcure Pharmaceuticals Limited
Incorporated in 1981, Emcure Pharmaceuticals Ltd manufactures and markets pharmaceutical products globally[1]
Healthcare · Pharmaceuticals & Biotechnology
Related Analysis
Frequently Asked Questions
What is Emcure Pharmaceuticals Limited share price today?▾
Emcure Pharmaceuticals Limited (EMCURE) is currently trading at ₹1,756.8 on NSE, up 0.66% as of the last market session. Prices update daily after market close on MarketNetra.
Is Emcure Pharmaceuticals Limited available in F&O (Futures & Options)?▾
Yes, Emcure Pharmaceuticals Limited (EMCURE) is part of the NSE F&O segment with a lot size of 1 shares. Options are available with monthly expiry contracts. You can track the full option chain and OI analysis on MarketNetra.
What is Emcure Pharmaceuticals Limited 52-week high and low?▾
Emcure Pharmaceuticals Limited's 52-week high is ₹1,830 and the 52-week low is ₹1,229. The current price of ₹1,756.8 is 4.0% below the 52W high.
What is Emcure Pharmaceuticals Limited P/E ratio?▾
Emcure Pharmaceuticals Limited's current P/E ratio is 34.2. This indicates the market is paying ₹34.2 for every ₹1 of earnings. Compare this to the sector average to assess relative valuation.
How to trade Emcure Pharmaceuticals Limited options?▾
Emcure Pharmaceuticals Limited options are traded on NSE with monthly expiry contracts (lot size: 1 shares). To trade EMCURE options: select your expiry on the option chain page, identify key OI strikes, check the PCR and buildup type on OI analysis, and review FII/DII flows for institutional sentiment before taking a position.